• Activity related to phase III clinical trial in head and neck cancer to boost the immune system before the ravages of surgery, radiation and chemotherapy. The Phase III trial is the largest ever in head and neck cancer with 928 patients enrolled. LEAPS COVID-19 Immunotherapyas a new immune-based treatment for COVID-19

Duration: June 17, 2019 to December 15, 2020

General Issues: Medical/Disease Research/Clinical Labs, Health Issues

Spending: about $290,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2019: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Food & Drug Administration (FDA), Vice President of the U.S., Office of Management & Budget (OMB)